Bhavana J. Dave - Publications

Affiliations: 
University of Nebraska Medical Center, Omaha, NE, United States 
Area:
Pathology, Molecular Biology, Oncology

74 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Smith SC, Qdaisat TZS, Althof PA, Dave BJ, Sanmann JN. MECOM rearrangement involving the MYC locus: Two additional patients with the rare translocation, t(3;8)(q26.2;q24), and molecular review. Leukemia Research. 95: 106387. PMID 32535247 DOI: 10.1016/J.Leukres.2020.106387  0.383
2020 Smith SC, Althof PA, Dave BJ, Sanmann JN. High-risk cytogenetics in multiple myeloma: Further scrutiny of deletions within the IGH gene region enhances risk stratification. Genes, Chromosomes & Cancer. PMID 32447782 DOI: 10.1002/Gcc.22874  0.324
2017 Hassan HM, Varney ML, Althof PA, Caponetti GC, Fu K, Weisenburger DD, Singh RK, Dave BJ. Abstract 2157: P73 isoforms regulate cellular survival and response to treatment in diffuse large B-cell lymphoma Cancer Research. 77: 2157-2157. DOI: 10.1158/1538-7445.Am2017-2157  0.626
2016 Hassan HM, Varney ML, Chaturvedi NK, Joshi SS, Weisenburger DD, Singh RK, Dave BJ. Modulation of p73 isoforms expression induces anti-proliferative and pro-apoptotic activity in mantle cell lymphoma independent of p53 status. Leukemia & Lymphoma. 1-16. PMID 27074052 DOI: 10.3109/10428194.2016.1165814  0.645
2016 Heavican TB, Yu J, Bouska A, Greiner TC, Lachel CM, Wang C, Dave BJ, Amador CC, Fu K, Vose JM, Weisenburger DD, Gascoyne RD, Hartmann S, Pedersen MB, Wilcox R, et al. Molecular Subgroups of Peripheral T-Cell Lymphoma Evolve By Distinct Genetic Pathways Blood. 128: 4096-4096. DOI: 10.1182/Blood.V128.22.4096.4096  0.416
2015 Caponetti GC, Dave BJ, Perry AM, Smith LM, Jain S, Meyer PN, Bast M, Bierman PJ, Bociek RG, Vose JM, Armitage JO, Aoun P, Fu K, Greiner TC, Chan WC, et al. Isolated MYC cytogenetic abnormalities in diffuse large B-cell lymphoma do not predict an adverse clinical outcome. Leukemia & Lymphoma. 1-8. PMID 25827211 DOI: 10.3109/10428194.2015.1034699  0.42
2015 Bhatt VR, Bociek RG, Yuan J, Fu K, Greiner TC, Dave BJ, Rajan SK, Armitage JO. Leukemic diffuse large B-cell lymphoma in a patient with myeloproliferative disorder. Journal of the National Comprehensive Cancer Network : Jnccn. 13: 281-7. PMID 25736004 DOI: 10.6004/Jnccn.2015.0039  0.34
2015 Hassan HM, Varney ML, Aly AM, Joshi SS, Singh RK, Dave BJ. Abstract 2632: The COX inhibitor, diclofenac induces mantle cell lymphoma apoptosis independent of p53 status Cancer Research. 75: 2632-2632. DOI: 10.1158/1538-7445.Am2015-2632  0.669
2014 Hassan HM, Dave BJ, Singh RK. TP73, an under-appreciated player in non-Hodgkin lymphoma pathogenesis and management. Current Molecular Medicine. 14: 432-9. PMID 24730526 DOI: 10.2174/1566524014666140414204458  0.644
2014 Hassan HM, Varney ML, Jain S, Weisenburger DD, Singh RK, Dave BJ. Disruption of chromosomal locus 1p36 differentially modulates TAp73 and ΔNp73 expression in follicular lymphoma. Leukemia & Lymphoma. 55: 2924-31. PMID 24660851 DOI: 10.3109/10428194.2014.900759  0.675
2014 Bouska A, McKeithan TW, Deffenbacher KE, Lachel C, Wright GW, Iqbal J, Smith LM, Zhang W, Kucuk C, Rinaldi A, Bertoni F, Fitzgibbon J, Fu K, Weisenburger DD, Greiner TC, ... Dave BJ, et al. Genome-wide copy-number analyses reveal genomic abnormalities involved in transformation of follicular lymphoma. Blood. 123: 1681-90. PMID 24037725 DOI: 10.1182/Blood-2013-05-500595  0.43
2014 Hassan H, Varney M, Dave BJ, Singh RK. Diclofenac Induces Apoptosis and Suppresses Diffuse Large B-Cell Lymphoma Proliferation Independent of P53 Status Blood. 124: 5485-5485. DOI: 10.1182/Blood.V124.21.5485.5485  0.681
2014 Hassan HM, Varney ML, Singh rK, Dave BJ. Abstract 2738: Expression of p73 isoforms regulates proliferation and chemotherapeutic response in diffuse large B-cell lymphoma Cancer Research. 74: 2738-2738. DOI: 10.1158/1538-7445.Am2014-2738  0.684
2014 Utter RA, Pickering DL, Stevens JM, Althof PA, Sanger WG, Dave BJ. Microarray Detects Variation in Deletions of IGH (14q32) Gene Region in CLL Cancer Genetics. 207: 286. DOI: 10.1016/J.Cancergen.2014.06.007  0.327
2013 Kanev I, Mei WN, Mizuno A, Dehaai K, Sanmann J, Hess M, Starr L, Grove J, Dave B, Sanger W. Searching for electrical properties, phenomena and mechanisms in the construction and function of chromosomes. Computational and Structural Biotechnology Journal. 6: e201303007. PMID 24688715 DOI: 10.5936/Csbj.201303007  0.3
2013 Chen Y, Dave BJ, Zhu X, Chan WC, Iqbal J, Sanger WG, Fu K. Differences in the cytogenetic alteration profiles of diffuse large B-cell lymphoma among Chinese and American patients Cancer Genetics. 206: 183-190. PMID 23849050 DOI: 10.1016/J.Cancergen.2013.05.001  0.424
2013 Perry AM, Crockett D, Dave BJ, Althof P, Winkler L, Smith LM, Aoun P, Chan WC, Fu K, Greiner TC, Bierman P, Gregory Bociek R, Vose JM, Armitage JO, Weisenburger DD. B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and burkitt lymphoma: study of 39 cases. British Journal of Haematology. 162: 40-9. PMID 23600716 DOI: 10.1111/Bjh.12343  0.397
2013 Küçük C, Hu X, Iqbal J, Gaulard P, Klinkebiel D, Cornish A, Dave BJ, Chan WC. HACE1 is a tumor suppressor gene candidate in natural killer cell neoplasms. The American Journal of Pathology. 182: 49-55. PMID 23142381 DOI: 10.1016/J.Ajpath.2012.09.012  0.394
2013 Aschebrook-Kilfoy B, Ward MH, Dave BJ, Smith SM, Weisenburger DD, Chiu BC. Dietary nitrate and nitrite intake and risk of non-Hodgkin lymphoma. Leukemia & Lymphoma. 54: 945-50. PMID 23013327 DOI: 10.3109/10428194.2012.734613  0.33
2013 Mirza S, Mohibi S, Katafiasz BJ, Wang J, Dave BJ, Rakha EA, Alshareeda A, Band H, Band V. Abstract B120: Ada3, a component of ATAC complex is involved in regulation of the Genomic stability, DNA repair process and breast cancer Molecular Cancer Research. 11. DOI: 10.1158/1557-3125.Advbc-B120  0.347
2013 Dave B, Jing H, Sanmann J, Althof P, Wiggins M, Higgins C, Sanger W, Akhtari M. P-047 Combined cytogenetic and FISH studies facilitate abnormality detection in myelodysplastic syndromes: A comprehensive analysis of 1132 consecutive specimens Leukemia Research. 37: S43. DOI: 10.1016/S0145-2126(13)70096-1  0.342
2012 Ahrens AK, Chaturvedi NK, Nordgren TM, Dave BJ, Joshi SS. Establishment and characterization of therapy-resistant mantle cell lymphoma cell lines derived from different tissue sites. Leukemia & Lymphoma. 53: 2269-78. PMID 22568512 DOI: 10.3109/10428194.2012.691481  0.34
2012 Hassan HM, Varney ML, Joshi SS, Singh RK, Dave BJ. Abstract 1180: Modulation of p73 isoform expression regulates aggressive behavior in NHL cell line model with 1p36 chromosomal disruption Cancer Research. 72: 1180-1180. DOI: 10.1158/1538-7445.Am2012-1180  0.522
2011 Morton LM, Cerhan JR, Hartge P, Vasef MA, Neppalli VT, Natkunam Y, Dogan A, Dave BJ, Jain S, Levy R, Lossos IS, Cozen W, Davis S, Schenk MJ, Maurer MJ, et al. Immunostaining to identify molecular subtypes of diffuse large B-cell lymphoma in a population-based epidemiologic study in the pre-rituximab era. International Journal of Molecular Epidemiology and Genetics. 2: 245-52. PMID 21915363  0.313
2011 Chang CM, Wang SS, Dave BJ, Jain S, Vasef MA, Weisenburger DD, Cozen W, Davis S, Severson RK, Lynch CF, Rothman N, Cerhan JR, Hartge P, Morton LM. Risk factors for non-Hodgkin lymphoma subtypes defined by histology and t(14;18) in a population-based case-control study. International Journal of Cancer. Journal International Du Cancer. 129: 938-47. PMID 20949561 DOI: 10.1002/Ijc.25717  0.322
2011 Hassan HM, Varney ML, Jain S, Weisenburger DD, Singh RK, Dave BJ. Abstract 312: Disruption of chromosomal locus 1p36 differentially modulates TAp73 and ΔNp73 expression and aggressiveness in non-Hodgkin's lymphoma Cancer Research. 71: 312-312. DOI: 10.1158/1538-7445.Am2011-312  0.675
2011 Hassan HM, Varney ML, Jain S, Joshi SS, Singh RK, Dave BJ. Abstract 222: Differential p73 isoform expression profile in non-Hodgkin's lymphoma with 1p36 chromosomal abnormality modulates angiogenic phenotype Cancer Research. 71: 222-222. DOI: 10.1158/1538-7445.Am2011-222  0.667
2010 Nelson M, Perkins SL, Dave BJ, Coccia PF, Bridge JA, Lyden ER, Heerema NA, Lones MA, Harrison L, Cairo MS, Sanger WG. An increased frequency of 13q deletions detected by fluorescence in situ hybridization and its impact on survival in children and adolescents with Burkitt lymphoma: results from the Children's Oncology Group study CCG-5961. British Journal of Haematology. 148: 600-10. PMID 19895612 DOI: 10.1111/J.1365-2141.2009.07967.X  0.394
2009 Balasubramanian S, Babai N, Chaudhuri A, Qiu F, Bhattacharya S, Dave BJ, Parameswaran S, Carson SD, Thoreson WB, Sharp JG, Rao M, Ahmad I. Non cell-autonomous reprogramming of adult ocular progenitors: generation of pluripotent stem cells without exogenous transcription factors. Stem Cells (Dayton, Ohio). 27: 3053-62. PMID 19859985 DOI: 10.1002/Stem.242  0.336
2009 Dave BJ, Olney AH, Zaleski DH, Pickering DL, Becker TA, Chipman HE, Sanger WG. Inherited 14q duplication and 21q deletion: a rare adjacent-2 segregation in multiple family members. American Journal of Medical Genetics. Part A. 149: 2248-53. PMID 19760655 DOI: 10.1002/Ajmg.A.32999  0.361
2009 Gu K, Fu K, Jain S, Liu Z, Iqbal J, Li M, Sanger WG, Weisenburger DD, Greiner TC, Aoun P, Dave BJ, Chan WC. t(14;18)-negative follicular lymphomas are associated with a high frequency of BCL6 rearrangement at the alternative breakpoint region. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc. 22: 1251-7. PMID 19465899 DOI: 10.1038/Modpathol.2009.81  0.404
2008 Chew YC, West JT, Kratzer SJ, Ilvarsonn AM, Eissenberg JC, Dave BJ, Klinkebiel D, Christman JK, Zempleni J. Biotinylation of histones represses transposable elements in human and mouse cells and cell lines and in Drosophila melanogaster. The Journal of Nutrition. 138: 2316-22. PMID 19022951 DOI: 10.3945/Jn.108.098673  0.315
2008 d'Amore F, Chan E, Iqbal J, Geng H, Young K, Xiao L, Hess MM, Sanger WG, Smith L, Wiuf C, Hagberg O, Fu K, Chan WC, Dave BJ. Clonal evolution in t(14;18)-positive follicular lymphoma, evidence for multiple common pathways, and frequent parallel clonal evolution. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 14: 7180-7. PMID 19010834 DOI: 10.1158/1078-0432.Ccr-08-0752  0.358
2008 Chiu BC, Lan Q, Dave BJ, Blair A, Zahm SH, Weisenburger DD. The utility of t(14;18) in understanding risk factors for non-Hodgkin lymphoma. Journal of the National Cancer Institute. Monographs. 69-73. PMID 18648007 DOI: 10.1093/Jncimonographs/Lgn018  0.383
2008 Bakshi SR, Dave BJ, Sanger W, Brahmbhatt MM, Trivedi PJ, Kakadia PM, Patel SJ. Characterization of a familial small supernumerary marker chromosome in a patient with adult-onset tongue cancer. Cytogenetic and Genome Research. 121: 14-7. PMID 18544921 DOI: 10.1159/000124376  0.335
2008 Pickering DL, Eudy JD, Olney AH, Dave BJ, Golden D, Stevens J, Sanger WG. Array-based comparative genomic hybridization analysis of 1176 consecutive clinical genetics investigations Genetics in Medicine. 10: 262-266. PMID 18414209 DOI: 10.1097/Gim.0B013E31816B64Ad  0.305
2008 Chiu BCH, Dave BJ, Ward MH, Fought AJ, Hou L, Jain S, Gapstur S, Evens AM, Zahm SH, Blair A, Weisenburger DD. Dietary factors and risk of t(14;18)-defined subgroups of non-Hodgkin lymphoma Cancer Causes and Control. 19: 859-867. PMID 18386141 DOI: 10.1007/S10552-008-9148-3  0.317
2008 Nelson M, Horsman DE, Weisenburger DD, Gascoyne RD, Dave BJ, Loberiza FR, Ludkovski O, Savage KJ, Armitage JO, Sanger WG. Cytogenetic abnormalities and clinical correlations in peripheral T-cell lymphoma. British Journal of Haematology. 141: 461-9. PMID 18341637 DOI: 10.1111/J.1365-2141.2008.07042.X  0.479
2007 Young KH, Weisenburger DD, Dave BJ, Smith L, Sanger W, Iqbal J, Campo E, Delabie J, Gascoyne RD, Ott G, Rimsza L, Müller-Hermelink HK, Jaffe ES, Rosenwald A, Staudt LM, et al. Mutations in the DNA-binding codons of TP53, which are associated with decreased expression of TRAILreceptor-2, predict for poor survival in diffuse large B-cell lymphoma. Blood. 110: 4396-405. PMID 17881637 DOI: 10.1182/Blood-2007-02-072082  0.332
2007 Mittal AK, Hegde GV, Aoun P, Bociek RG, Dave BJ, Joshi AD, Sanger WG, Weisenburger DD, Joshi SS. Molecular basis of aggressive disease in chronic lymphocytic leukemia patients with 11q deletion and trisomy 12 chromosomal abnormalities. International Journal of Molecular Medicine. 20: 461-9. PMID 17786276 DOI: 10.3892/Ijmm.20.4.461  0.44
2007 Iqbal J, Greiner TC, Patel K, Dave BJ, Smith L, Ji J, Wright G, Sanger WG, Pickering DL, Jain S, Horsman DE, Shen Y, Fu K, Weisenburger DD, Hans CP, et al. Distinctive patterns of BCL6 molecular alterations and their functional consequences in different subgroups of diffuse large B-cell lymphoma. Leukemia. 21: 2332-43. PMID 17625604 DOI: 10.1038/Sj.Leu.2404856  0.443
2007 Dave BJ, Sanger WG. Role of Cytogenetics and Molecular Cytogenetics in the Diagnosis of Genetic Imbalances Seminars in Pediatric Neurology. 14: 2-6. PMID 17331878 DOI: 10.1016/J.Spen.2006.11.003  0.331
2007 Chiu BC, Dave BJ, Blair A, Gapstur SM, Chmiel JS, Fought AJ, Zahm SH, Weisenburger DD. Cigarette smoking, familial hematopoietic cancer, hair dye use, and risk of t(14;18)-defined subtypes of non-Hodgkin's lymphoma. American Journal of Epidemiology. 165: 652-9. PMID 17204518 DOI: 10.1093/Aje/Kwk044  0.305
2006 Dave SS, Fu K, Wright GW, Lam LT, Kluin P, Boerma EJ, Greiner TC, Weisenburger DD, Rosenwald A, Ott G, Müller-Hermelink HK, Gascoyne RD, Delabie J, Rimsza LM, Braziel RM, ... ... Dave BJ, et al. Molecular diagnosis of Burkitt's lymphoma. The New England Journal of Medicine. 354: 2431-42. PMID 16760443 DOI: 10.1056/Nejmoa055759  0.374
2006 Chiu BC, Dave BJ, Blair A, Gapstur SM, Zahm SH, Weisenburger DD. Agricultural pesticide use and risk of t(14;18)-defined subtypes of non-Hodgkin lymphoma. Blood. 108: 1363-9. PMID 16621961 DOI: 10.1182/Blood-2005-12-008755  0.309
2006 Iqbal J, Neppalli VT, Wright G, Dave BJ, Horsman DE, Rosenwald A, Lynch J, Hans CP, Weisenburger DD, Greiner TC, Gascoyne RD, Campo E, Ott G, Müller-Hermelink HK, Delabie J, et al. BCL2 expression is a prognostic marker for the activated B-cell-like type of diffuse large B-cell lymphoma. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 24: 961-8. PMID 16418494 DOI: 10.1200/Jco.2005.03.4264  0.394
2006 Bierman P, Loberiza F, Dave B, Sanger W, Bociek RG, Bast M, Vose JM, Armitage JO, Weisenburger D. Significance of c-myc Rearrangements in Diffuse Large B-Cell Lymphoma. Blood. 108: 2030-2030. DOI: 10.1182/Blood.V108.11.2030.2030  0.358
2005 Dave BJ, Wiggins M, Higgins CM, Pickering DL, Perry D, Aoun P, Abromowich M, DeVetten M, Sanger WG. 9q34 rearrangements in BCR/ABL fusion-negative acute lymphoblastic leukemia. Cancer Genetics and Cytogenetics. 162: 30-7. PMID 16157197 DOI: 10.1016/J.Cancergencyto.2005.03.005  0.383
2005 Fu K, Weisenburger DD, Greiner TC, Dave S, Wright G, Rosenwald A, Chiorazzi M, Iqbal J, Gesk S, Siebert R, De Jong D, Jaffe ES, Wilson WH, Delabie J, Ott G, ... Dave BJ, et al. Cyclin D1-negative mantle cell lymphoma: a clinicopathologic study based on gene expression profiling. Blood. 106: 4315-21. PMID 16123218 DOI: 10.1182/Blood-2005-04-1753  0.348
2005 Sanger TM, Olney AH, Zaleski D, Pickering D, Nelson M, Sanger WG, Dave BJ. Cryptic duplication and deletion of 9q34.3 --> qter in a family with a t(9;22)(q34.3;p11.2). American Journal of Medical Genetics. Part A. 138: 51-5. PMID 16104013 DOI: 10.1002/Ajmg.A.30922  0.394
2005 d’Amore F, Chan E, Li X, Iqbal J, Sherman S, Hess MM, Sanger WG, Chan WC, Dave BJ. Clonal Genetic Progression in t(14;18)-Positive Follicular Lymphomas. Blood. 106: 995-995. DOI: 10.1182/Blood.V106.11.995.995  0.405
2005 Iqbal J, Greiner TC, Patel K, Ji J, Dave BJ, Horsman DE, Shen Y, Weisenburger DD, Campo E, Rosenwald A, Gascoyne RD, Jaffe ES, Ott G, Delabie J, Rimsza L, et al. Distinctive Patterns of BCL6 Molecular Alterations in Different Subsets of Diffuse Large B-Cell Lymphoma and Their Functional Consequences. Blood. 106: 160-160. DOI: 10.1182/Blood.V106.11.160.160  0.421
2004 Aoun P, Blair HE, Smith LM, Dave BJ, Lynch J, Weisenburger DD, Pavletic SZ, Sanger WG. Fluorescence in situ hybridization detection of cytogenetic abnormalities in B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma. Leukemia & Lymphoma. 45: 1595-603. PMID 15370211 DOI: 10.1080/10428190410001680546  0.456
2004 Iqbal J, Sanger WG, Horsman DE, Rosenwald A, Pickering DL, Dave B, Dave S, Xiao L, Cao K, Zhu Q, Sherman S, Hans CP, Weisenburger DD, Greiner TC, Gascoyne RD, et al. BCL2 translocation defines a unique tumor subset within the germinal center B-cell-like diffuse large B-cell lymphoma. The American Journal of Pathology. 165: 159-66. PMID 15215171 DOI: 10.1016/S0002-9440(10)63284-1  0.433
2003 Varney ML, Li A, Dave BJ, Bucana CD, Johansson SL, Singh RK. Expression of CXCR1 and CXCR2 receptors in malignant melanoma with different metastatic potential and their role in interleukin-8 (CXCL-8)-mediated modulation of metastatic phenotype. Clinical & Experimental Metastasis. 20: 723-31. PMID 14713106 DOI: 10.1023/B:Clin.0000006814.48627.Bd  0.33
2003 Hayami Y, Iida S, Nakazawa N, Hanamura I, Kato M, Komatsu H, Miura I, Dave BJ, Sanger WG, Lim B, Taniwaki M, Ueda R. Inactivation of the E3/LAPTm5 gene by chromosomal rearrangement and DNA methylation in human multiple myeloma. Leukemia. 17: 1650-7. PMID 12886255 DOI: 10.1038/sj.leu.2403026  0.313
2003 Rosenwald A, Wright G, Wiestner A, Chan WC, Connors JM, Campo E, Gascoyne RD, Grogan TM, Muller-Hermelink HK, Smeland EB, Chiorazzi M, Giltnane JM, Hurt EM, Zhao H, Averett L, ... ... Dave BJ, et al. The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma. Cancer Cell. 3: 185-97. PMID 12620412 DOI: 10.1016/S1535-6108(03)00028-X  0.41
2002 Rosenwald A, Wright G, Chan WC, Connors JM, Campo E, Fisher RI, Gascoyne RD, Muller-Hermelink HK, Smeland EB, Giltnane JM, Hurt EM, Zhao H, Averett L, Yang L, Wilson WH, ... ... Dave BJ, et al. The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. The New England Journal of Medicine. 346: 1937-47. PMID 12075054 DOI: 10.1056/Nejmoa012914  0.416
2002 Patel PS, Varney ML, Dave BJ, Singh RK. Regulation of constitutive and induced NF-kappaB activation in malignant melanoma cells by capsaicin modulates interleukin-8 production and cell proliferation. Journal of Interferon & Cytokine Research : the Official Journal of the International Society For Interferon and Cytokine Research. 22: 427-35. PMID 12034025 DOI: 10.1089/10799900252952217  0.3
2002 Dave BJ, Nelson M, Pickering DL, Chan WC, Greiner TC, Weisenburger DD, Armitage JO, Sanger WG. Cytogenetic characterization of diffuse large cell lymphoma using multi-color fluorescence in situ hybridization Cancer Genetics and Cytogenetics. 132: 125-132. PMID 11850073 DOI: 10.1016/S0165-4608(01)00548-9  0.455
2000 Dave B, Watanabe T, Singh RK, Ageitos A, Heimann DG, Talmadge JE. Growth factor mobilization and modulation of progenitor cell adhesion to stromal cells: Role of VLA-4 Journal of Hematotherapy and Stem Cell Research. 9: 507-515. PMID 10982250 DOI: 10.1089/152581600419189  0.329
2000 Weisenburger DD, Vose JM, Greiner TC, Lynch JC, Chan WC, Bierman PJ, Dave BJ, Sanger WG, Armitage JO. Mantle cell lymphoma. A clinicopathologic study of 68 cases from the Nebraska Lymphoma Study Group. American Journal of Hematology. 64: 190-6. PMID 10861815 DOI: 10.1002/1096-8652(200007)64:3<190::Aid-Ajh9>3.0.Co;2-B  0.356
1999 Arcaroli JJ, Dave BJ, Pickering DL, Hess MM, Armitage JO, Weisenburger DD, Sanger WG. Is a duplication of 14q32 a new recurrent chromosomal alteration in B-cell Non-Hodgkin lymphoma? Cancer Genetics and Cytogenetics. 113: 19-24. PMID 10459341 DOI: 10.1016/S0165-4608(98)00286-6  0.393
1999 Dave BJ, Pickering DL, Hess MM, Weisenburger DD, Armitage JO, Sanger WG. Deletion of cell division cycle 2-like 1 gene locus on 1p36 in non- Hodgkin lymphoma Cancer Genetics and Cytogenetics. 108: 120-126. PMID 9973938 DOI: 10.1016/S0165-4608(98)00138-1  0.48
1997 Pfeifer A, Hess M, Pickering D, Dave B, Zaleski D, Sanger W. 1p36 Rearrangements may be important in non-Hodgkin's lymphoma Cancer Genetics and Cytogenetics. 98: 164. DOI: 10.1016/S0165-4608(97)90296-X  0.388
1993 Trivedi AH, Dave BJ, Adhvaryu SG. Genotoxic effects of tobacco extract on Chinese hamster ovary cells. Cancer Letters. 70: 107-12. PMID 8330291 DOI: 10.1016/0304-3835(93)90081-J  0.331
1992 Dave BJ, Trivedi AH, Adhvaryu SG. In vitro genotoxic effects of areca nut extract and arecoline. Journal of Cancer Research and Clinical Oncology. 118: 283-8. PMID 1577847 DOI: 10.1007/Bf01208617  0.326
1992 Jaju RJ, Patel RK, Bakshi SR, Trivedi AH, Dave BJ, Adhvaryu SG. Chromosome damaging effects of pan masala. Cancer Letters. 65: 221-6. PMID 1516036 DOI: 10.1016/0304-3835(92)90235-N  0.345
1991 Dave BJ, Trivedi AH, Adhvaryu SG. Cytogenetic studies reveal increased genomic damage among 'pan masala' consumers. Mutagenesis. 6: 159-63. PMID 2056918 DOI: 10.1093/Mutage/6.2.159  0.335
1991 Dave BJ, Trivedi AH, Adhvaryu SG. Variations in centromeric heterochromatin among patients with pre-malignant and malignant oral diseases. International Journal of Cancer. 48: 386-9. PMID 2040533 DOI: 10.1002/Ijc.2910480313  0.331
1991 Adhvaryu SG, Dave BJ, Trivedi AH. Cytogenetic surveillance of tobacco-areca nut (mava) chewers, including patients with oral cancers and premalignant conditions. Mutation Research. 261: 41-9. PMID 1881407 DOI: 10.1016/0165-1218(91)90096-5  0.308
1989 Adhvaryu SG, Dave BJ, Trivedi AH, Rawal UM, Jani KH. Variability of Euchromatic and Heterochromatic Regions of Y Chromosome in Two Types of Cancer Patients Tumori Journal. 75: 547-549. DOI: 10.1177/030089168907500606  0.33
1987 Adhvaryu SG, Dave BJ, Trivedi AH, Jani KH, Vyas RC. Heteromorphism of C-band positive chromosomal regions in CML patients. Cancer Genetics and Cytogenetics. 27: 33-8. PMID 3472647 DOI: 10.1016/0165-4608(87)90257-3  0.344
1985 Adhvaryu SG, Vyas RC, Dave BJ, Trivedi AH, Parikh BN. Spontaneous and induced sister chromatid exchange frequencies and cell cycle progression in lymphocytes of patients with carcinoma of the uterine cervix. Cancer Genetics and Cytogenetics. 14: 67-72. PMID 3917367 DOI: 10.1016/0165-4608(85)90216-X  0.332
Show low-probability matches.